Simvastatin and Rifaximin as new therapy for patients with decompensated cirrhosis

Scientific director: prof. Caraceni Paolo

Areas: Internal Medicine and Specialties

Funding body: COMMISSIONE EUROPEA

Duration: 01/01/2017 - 31/12/2021